Autres langues Crossject

Actions

ALCJ

FR0011716265

Equipement, fournitures et distribution médicale

PEA/PME

Marché Fermé - Euronext Paris Autres places de cotation 17:36:50 23/06/2025			Varia. 5j.	Varia. 1 janv.
1,628 ^EUR	-4,68 %		-7,92 %	-26,67 %

11/06	Crossject : des avancées en matière de pédiatrie	CF
11/06	Avancées Interprojets dans le Développement de Zepizure Junior	CI

Autres langues

CROSSJECT advances on the development of ZEPIZURE Junior, its solution for epilepsy crises in children	12/06
Cross Project Advances on the Development of Zepizure Junior	11/06
CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children	11/06
CROSSJECT : Here we are for the announced capital increase	09/06
Crossject : Launch of a capital increase with preferential subscription rights for nearly 5 million euros	04/06
Launch of a capital increase with preferential subscription rights for nearly 5 million euros	04/06
Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of EUR4.00	04/06
Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of €4.00	03/06
CROSSJECT : implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment	27/05
CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment	27/05
CROSSJECT : Another capital increase in the pipe…	21/05
Crossject Société Anonyme announced that it expects to receive ?5 million in funding	21/05
France's Crossject Plans Up to EUR6 Million Capital Raise	20/05
CROSSJECT : prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approval	20/05
CROSSJECT prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approval	20/05
CROSSJECT : ZENEO® needle-free autoinjector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors	15/05
CROSSJECT’s ZENEO® needle-free autoinjector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors	15/05
CROSSJECT : Back to life?	07/05
CROSSJECT : fait un point sur les dernières avancées dans le dépôt de la demande EUA de ZEPIZURE®	07/05
CROSSJECT provides updates on the EUA filing of ZEPIZURE®	07/05
Mise à disposition du rapport financier annuel 2024	30/04
CROSSJECT : Integrating the FY24 numbers.	30/03
CROSSJECT : FY24 and outlook: long is the road…	27/03
CROSSJECT reports financial results for 2024	27/03
Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	27/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Crossject

Actions

ALCJ

FR0011716265

Equipement, fournitures et distribution médicale

PEA/PME

Autres langues

Filtres